Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
CSL Vifor announced that its partner Akebia Therapeutics, Inc. has received FDA approval for Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months. Vafseo is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) developed by Akebia.
read more
Natoli Engineering, the world-renowned leader in tablet compression tooling, presses, machine parts, and encapsulation, is excited to announce the hiring of longtime expert in the field, Todd D. Martin, into his new role as Senior Technical Service Engineer. Prior to his role at Natoli, Mr. Martin served as a Senior Tooling Engineer at Wilson Tool International for over five years, and in multiple tooling-related roles for over 22 years at Thomas Engineering.
read more
Endo International announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS®.
read more
Viking Therapeutics, Inc. announced positive results from the company's Phase 1 multiple ascending dose (MAD) clinical trial of an oral tablet formulation of VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, in development for the potential treatment of metabolic disorders such as obesity.
read more
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, today announced it has signed an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Roche for USD 1.2 billion.
read more
Hovione, an integrated CDMO and provider of spray drying and particle engineering, and GEA, a provider of process technology for the pharmaceutical industry, announced the next stage of their partnership, with new development agreements, the launch of the ConsiGma® CDC flex as well as the installation of a new lab-scale R&D Continuous Tableting rig in Hovione´s facilities in Portugal.
read more
Journey Medical Corporation announced that the FDA has accepted the Company’s New Drug Application (“NDA”) for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the treatment of inflammatory lesions and erythema of rosacea in adults.
read more
The Boehringer Ingelheim Cares Foundation, through its Product Donation Program, has made a significant contribution to animal shelters across the country.
read more
American Pharmaceutical Review, Pharmaceutical Outsourcing, and Tablets & Capsules magazines are excited to announce the joint release of a new video documentary titled "A Solid Dosage Future", which is now available for viewing on all three platforms. This documentary takes a look at current challenges with solid dosage products and the future landscape for these products,
read more
Almac Sciences, a member of the Almac Group, has been awarded a Life Sciences Innovative Manufacturing Fund (LSIMF) Grant to support the expansion of its small molecule active pharmaceutical ingredients (API) manufacturing facility at its Global Headquarters in Craigavon, UK.
read more
Xcovery Holdings, Inc., announced that the FDA accepted the New Drug Application (NDA) for ensartinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor for the treatment of adult patients with metastatic ALK-positive non-small cell lung cancer (NSCLC).
read more
IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, announced that Novartis has exercised its option to acquire all of the outstanding capital stock of IFM Due, a subsidiary company of IFM.
read more
Adare Pharma Solutions announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear mixer granulator to complement existing fluid bed capabilities. This addition follows the recently announced expansion of blister packaging and warehousing capabilities at the site.
read more
The U.S. FDA announced it is requesting $7.2 billion as part of the President's fiscal year (FY) 2025 proposed budget.
read more
CAPTEK® Softgel International, a contract manufacturer of dietary supplements has officially begun gummy supplement production in La Mirada, California.
read more